DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,453 | +8.9% | 34,072 | +5.4% | 0.20% | +27.4% |
| Q2 2023 | $7,759 | +39.1% | 32,331 | +46.0% | 0.16% | +19.8% |
| Q1 2023 | $5,580 | -99.9% | 22,138 | -44.5% | 0.13% | -51.8% |
| Q3 2022 | $10,299,000 | +266.5% | 39,875 | +366.9% | 0.27% | +331.7% |
| Q4 2021 | $2,810,000 | +50.6% | 8,541 | +39.4% | 0.06% | +57.5% |
| Q3 2021 | $1,866,000 | -28.1% | 6,128 | -36.6% | 0.04% | -29.8% |
| Q2 2021 | $2,595,000 | -62.0% | 9,671 | -68.1% | 0.06% | -62.0% |
| Q1 2021 | $6,831,000 | +148.5% | 30,348 | +145.2% | 0.15% | +183.0% |
| Q4 2020 | $2,749,000 | -66.1% | 12,377 | -67.2% | 0.05% | -75.5% |
| Q3 2020 | $8,117,000 | +9.2% | 37,697 | -10.3% | 0.22% | +1.4% |
| Q2 2020 | $7,432,000 | +48.7% | 42,029 | -20.2% | 0.21% | -1.8% |
| Q1 2016 | $4,997,000 | +103.0% | 52,681 | +98.8% | 0.22% | +27.6% |
| Q4 2015 | $2,461,000 | +43.2% | 26,494 | +31.4% | 0.17% | +123.7% |
| Q3 2015 | $1,719,000 | -95.8% | 20,169 | -95.8% | 0.08% | -95.3% |
| Q2 2015 | $41,092,000 | +1393.7% | 480,100 | +1381.8% | 1.62% | +1230.3% |
| Q1 2015 | $2,751,000 | +127.5% | 32,400 | +129.8% | 0.12% | +190.5% |
| Q4 2014 | $1,209,000 | -80.0% | 14,100 | -81.6% | 0.04% | -67.9% |
| Q2 2014 | $6,044,000 | -31.9% | 76,766 | -35.1% | 0.13% | -26.8% |
| Q1 2014 | $8,878,000 | -49.4% | 118,370 | -47.9% | 0.18% | -52.6% |
| Q4 2013 | $17,534,000 | -57.6% | 227,130 | -61.9% | 0.38% | -15.1% |
| Q3 2013 | $41,332,000 | +986.5% | 596,240 | +892.3% | 0.44% | +300.9% |
| Q2 2013 | $3,804,000 | – | 60,088 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |